share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

諾瓦瓦克斯醫藥 | 4：持股變動聲明-董事 MCGLYNN MARGARET G
美股sec公告 ·  06/15 04:21
牛牛AI助理已提取核心訊息
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
2024年6月12日，瑪格麗特·G·麥克格林（Margaret G. McGlynn）報告了一筆已完成的交易，涉及以每股0.00美元的價格收購諾瓦瓦克斯醫藥（Novavax Inc（NVAX））普通股6,670股。此交易被歸類爲直接由麥克格林進行的衍生證券的行使或轉換。此次交易後，麥克格林在諾瓦瓦克斯醫藥的直接持股增加至10,470股。此交易反映出麥克格林對公司的重要投資，並可能表明對諾瓦瓦克斯醫藥未來業績的信心。
2024年6月12日，瑪格麗特·G·麥克格林（Margaret G. McGlynn）報告了一筆已完成的交易，涉及以每股0.00美元的價格收購諾瓦瓦克斯醫藥（Novavax Inc（NVAX））普通股6,670股。此交易被歸類爲直接由麥克格林進行的衍生證券的行使或轉換。此次交易後，麥克格林在諾瓦瓦克斯醫藥的直接持股增加至10,470股。此交易反映出麥克格林對公司的重要投資，並可能表明對諾瓦瓦克斯醫藥未來業績的信心。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。